“…[11] AM IP shell specific for glucuronic acid (GlcA;g reen-QDs) or N-acetylneuraminic acid (NANA; red-QDs) was grafted on top of the hydrophilic first shell ( Figure 1B)t o target glycosylation sites on cells,s ince altered glycosylation levels or distributions are indicators of infection or malignancy.R ecent advances in glycobiology and cancer research have defined the key processes underlying aberrant glycosylation with sialic acids or hyaluronan in cancer and its consequences. [23][24][25] In this study,M IP-coated QDs were applied for the first time for the simultaneous multiplexed pseudoimmunolabeling and imaging of human keratinocytes.C ore-shell MIP nanoparticles for GlcA and NANA,( 125 AE 17) nm in size, were obtained, thus enabling the specific targeting of both intracellular and pericellular terminal glycosylations.W e previously reported 400 nm rhodamine-labeled MIP particles specific for GlcA that could only target the extracellular hyaluronan of the cell glycocalix. [17,18] MIPs are tailormade synthetic antibody mimics that can recognize and bind target molecules specifically.They are synthesized by copolymerizing functional and cross-linking monomers in the presence of am olecular template,t hus resulting in the formation of binding sites with affinities and specificities comparable to those of natural antibodies.T heir molecularrecognition properties,c ombined with ah igh chemical and physical stability,m ake them interesting substitutes for antibodies in immunoassays, [19] biosensors, [20] bioseparation, [18,21] controlled drug release, [22] and bioimaging.…”